- Home
- IMVT vs RXO Comparison
IMVT vs RXO Comparison
Compare IMVT & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- RXO
- Stock Information
- Founded
- IMVT 2018
- RXO 2022
- Country
- IMVT United States
- RXO United States
- Employees
- IMVT N/A
- RXO N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- RXO
- Sector
- IMVT Health Care
- RXO
- Exchange
- IMVT Nasdaq
- RXO Nasdaq
- Market Cap
- IMVT 2.8B
- RXO 2.6B
- IPO Year
- IMVT N/A
- RXO N/A
- Fundamental
- Price
- IMVT $15.80
- RXO $15.18
- Analyst Decision
- IMVT Buy
- RXO Hold
- Analyst Count
- IMVT 10
- RXO 17
- Target Price
- IMVT $40.14
- RXO $20.80
- AVG Volume (30 Days)
- IMVT 1.3M
- RXO 1.3M
- Earning Date
- IMVT 08-05-2025
- RXO 08-06-2025
- Dividend Yield
- IMVT N/A
- RXO N/A
- EPS Growth
- IMVT N/A
- RXO N/A
- EPS
- IMVT N/A
- RXO N/A
- Revenue
- IMVT N/A
- RXO $5,070,000,000.00
- Revenue This Year
- IMVT N/A
- RXO $35.30
- Revenue Next Year
- IMVT N/A
- RXO $7.33
- P/E Ratio
- IMVT N/A
- RXO N/A
- Revenue Growth
- IMVT N/A
- RXO 32.38
- 52 Week Low
- IMVT $12.72
- RXO $12.19
- 52 Week High
- IMVT $34.47
- RXO $32.82
- Technical
- Relative Strength Index (RSI)
- IMVT 53.39
- RXO 45.30
- Support Level
- IMVT $15.11
- RXO $15.05
- Resistance Level
- IMVT $17.08
- RXO $15.94
- Average True Range (ATR)
- IMVT 0.76
- RXO 0.61
- MACD
- IMVT -0.00
- RXO -0.11
- Stochastic Oscillator
- IMVT 47.56
- RXO 22.37
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.